116 related articles for article (PubMed ID: 14659653)
1. Investigation of methicillin-resistant Staphylococcus aureus showing reduced vancomycin susceptibility isolated from a patient with infective endocarditis.
Takayama Y; Hanaki H; Irinoda K; Kokubun H; Yoshida K; Sunakawa K
Int J Antimicrob Agents; 2003 Dec; 22(6):567-73. PubMed ID: 14659653
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of infective endocarditis clinical isolates of methicillin resistant Staphylococcus aureus non-responsive to vancomycin].
Takayama Y; Yoshida K; Yamaguchi Y; Nonoyama M; Endo T; Sunakawa K
Kansenshogaku Zasshi; 2001 Jun; 75(6):473-9. PubMed ID: 11494564
[TBL] [Abstract][Full Text] [Related]
3. Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
Chi CY; Lauderdale TL; Wang SM; Wu JM; Yang YJ; Liu CC
J Clin Microbiol; 2008 Feb; 46(2):810-3. PubMed ID: 18077634
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
[TBL] [Abstract][Full Text] [Related]
5. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.
Trakulsomboon S; Danchaivijitr S; Rongrungruang Y; Dhiraputra C; Susaemgrat W; Ito T; Hiramatsu K
J Clin Microbiol; 2001 Feb; 39(2):591-5. PubMed ID: 11158112
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.
Bae IG; Federspiel JJ; Miró JM; Woods CW; Park L; Rybak MJ; Rude TH; Bradley S; Bukovski S; de la Maria CG; Kanj SS; Korman TM; Marco F; Murdoch DR; Plesiat P; Rodriguez-Creixems M; Reinbott P; Steed L; Tattevin P; Tripodi MF; Newton KL; Corey GR; Fowler VG;
J Infect Dis; 2009 Nov; 200(9):1355-66. PubMed ID: 19811099
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis.
Hidalgo-Tenorio C; Gálvez J; Martínez-Marcos FJ; Plata-Ciezar A; De La Torre-Lima J; López-Cortés LE; Noureddine M; Reguera JM; Vinuesa D; García MV; Ojeda G; Luque R; Lomas JM; Lepe JA; de Alarcón A
BMC Infect Dis; 2020 Feb; 20(1):160. PubMed ID: 32085732
[TBL] [Abstract][Full Text] [Related]
8. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.
Pericàs JM; Messina JA; Garcia-de-la-Mària C; Park L; Sharma-Kuinkel BK; Marco F; Wray D; Kanafani ZA; Carugati M; Durante-Mangoni E; Tattevin P; Chu VH; Moreno A; Fowler VG; Miró JM;
Clin Microbiol Infect; 2017 Aug; 23(8):544-549. PubMed ID: 28159672
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
[TBL] [Abstract][Full Text] [Related]
10. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
[TBL] [Abstract][Full Text] [Related]
11. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Abdelhady W; Bayer AS; Seidl K; Nast CC; Kiedrowski MR; Horswill AR; Yeaman MR; Xiong YQ
Antimicrob Agents Chemother; 2013 Mar; 57(3):1447-54. PubMed ID: 23295925
[TBL] [Abstract][Full Text] [Related]
12. Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Lee DG; Chun HS; Yim DS; Choi SM; Choi JH; Yoo JH; Shin WS; Kang MW
Antimicrob Agents Chemother; 2003 Dec; 47(12):3768-73. PubMed ID: 14638480
[TBL] [Abstract][Full Text] [Related]
13. Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Cruces, New Mexico.
Delgado A; Riordan JT; Lamichhane-Khadka R; Winnett DC; Jimenez J; Robinson K; O'Brien FG; Cantore SA; Gustafson JE
J Clin Microbiol; 2007 Apr; 45(4):1325-9. PubMed ID: 17267639
[TBL] [Abstract][Full Text] [Related]
14. Identification of the first vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolate from a hospital in Portugal.
Gardete S; Aires-De-Sousa M; Faustino A; Ludovice AM; de Lencastre H
Microb Drug Resist; 2008 Mar; 14(1):1-6. PubMed ID: 18346009
[TBL] [Abstract][Full Text] [Related]
15. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.
Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I
Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of daptomycin and comparator agents against Staphylococcus aureus isolates from intravenous drug users with right endocarditis.
Sanchez-Porto A; Casanova-Roman M; Casas-Ciria J; Santaella MJ; Sanchez-Morenilla I; Eiros-Bouza JM
Infez Med; 2010 Jun; 18(2):108-12. PubMed ID: 20610933
[TBL] [Abstract][Full Text] [Related]
17. Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA).
Haque NZ; Davis SL; Manierski CL; Vager D; Donabedian SM; Perri MB; Sabbagh R; Cheema F; Zervos MJ
Int J Antimicrob Agents; 2007 Jul; 30(1):72-7. PubMed ID: 17428640
[TBL] [Abstract][Full Text] [Related]
18. Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin.
Heym B; Le Moal M; Armand-Lefevre L; Nicolas-Chanoine MH
J Antimicrob Chemother; 2002 Sep; 50(3):323-9. PubMed ID: 12205056
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
Saravolatz LD; Pawlak J; Johnson LB
Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
[TBL] [Abstract][Full Text] [Related]
20. An investigation of vancomycin minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus strains isolated from pediatric patients and healthy children in Northern Taiwan.
Chang CN; Lo WT; Chan MC; Yu CM; Wang CC
J Microbiol Immunol Infect; 2017 Jun; 50(3):362-369. PubMed ID: 26297168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
